NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled
NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT02974725 2025-04-13A Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaNovartisPhase 1 Terminated241 enrolled
NCT04452214 2023-07-14A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsCantargia ABPhase 1 Completed19 enrolled